However, some clinicians have suggested considering TRT for patients with a history of organ-confined PCa if they have undergone radical prostatectomy, have undetectable PSA for at least two years and low-grade PCa (Gleason score <7). The gene discussed is KLK3; the disease is posterior cortical atrophy.